Dr. Marc T. Roth
Claim this profileSaint Luke's Hospital of Kansas City
Area of expertise
Pancreatic Cancer
Marc T. Roth has run 1 trial for Pancreatic Cancer. Some of their research focus areas include:
Pancreatic Carcinoma
Marc T. Roth has run 1 trial for Pancreatic Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
Saint Luke's Hospital Of Kansas City
Saint Luke's East - Lee's Summit
Clinical Trials Marc T. Roth is currently running
Olaparib
for Pancreatic Cancer
This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.
Recruiting
0 awards
Phase 2
32 criteria
Chemotherapy Tailored by ctDNA Status
for Colon Cancer
This trial tests if a blood test for cancer DNA can help decide if colon cancer patients need more treatment after surgery. The test looks for cancer DNA in the blood to predict if the cancer might come back and to guide further treatment.
Recruiting
1 award
Phase 2 & 3
More about Marc T. Roth
Clinical Trial Related
4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Marc T. Roth has experience with
- Olaparib
- CAPOX
- MFOLFIRINOX
- MFOLFOX6
- Signatera Test
- Avelumab
Breakdown of trials Marc T. Roth has run
Pancreatic Cancer
Pancreatic Carcinoma
Bladder Cancer
Urethral Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marc T. Roth specialize in?
Marc T. Roth focuses on Pancreatic Cancer and Pancreatic Carcinoma. In particular, much of their work with Pancreatic Cancer has involved BRCA1 positive patients, or patients who are BRCA2 positive.
Is Marc T. Roth currently recruiting for clinical trials?
Yes, Marc T. Roth is currently recruiting for 2 clinical trials in Kansas City Missouri. If you're interested in participating, you should apply.
Are there any treatments that Marc T. Roth has studied deeply?
Yes, Marc T. Roth has studied treatments such as Olaparib, CAPOX, mFOLFIRINOX.
What is the best way to schedule an appointment with Marc T. Roth?
Apply for one of the trials that Marc T. Roth is conducting.
What is the office address of Marc T. Roth?
The office of Marc T. Roth is located at: Saint Luke's Hospital of Kansas City, Kansas City, Missouri 64111 United States. This is the address for their practice at the Saint Luke's Hospital of Kansas City.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.